Teradyne Declares Quarterly Cash Dividend
Get Alerts TER Hot Sheet
Join SI Premium – FREE
NORTH READING, Mass.--(BUSINESS WIRE)-- Teradyne, Inc. (NASDAQ: TER) today announced a quarterly cash dividend of $0.12 per share, payable on September 27, 2024, to shareholders of record as of the close of business on September 5, 2024.
About Teradyne
Teradyne (NASDAQ: TER) test technology helps bring high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its robotics offerings include collaborative and mobile robots that help manufacturers of all sizes increase productivity, improve safety, and lower costs. In 2023, Teradyne had revenue of $2.7 billion and today employs over 6,200 people worldwide. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc., in the U.S. and other countries.
Safe Harbor Statement
This release contains forward-looking statements regarding future business prospects, Teradyne's results of operations, market conditions and the payment of a quarterly dividend. Such statements are based on the current assumptions and expectations of Teradyne's management and are neither promises nor guarantees of future performance or future payment of dividends. Future dividend declarations, as well as record and payment dates, are subject to board approval.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240822721758/en/
Traci Tsuchiguchi
Investor Relations
Tel: 978.370.2444 [email protected]
Source: Teradyne, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coordinated Robot Fleets Are Fast Becoming the Next Frontier in Autonomous Operations
- Final Approval Received for Emera’s Sale of New Mexico Gas Company
- One Biosciences Announces Data Validating New Method for Single-Cell Transcriptomic Tumor Profiling from Clinical Pathology Samples
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share